Global Valsartan Drug Market Growth 2025-2031
The global Valsartan Drug market size is predicted to grow from US$ 653 million in 2025 to US$ 961 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Valsartan Drug Industry Forecast? looks at past sales and reviews total world Valsartan Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Valsartan Drug sales for 2025 through 2031. With Valsartan Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Valsartan Drug industry.
This Insight Report provides a comprehensive analysis of the global Valsartan Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Valsartan Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Valsartan Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Valsartan Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Valsartan Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Valsartan Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Valsartan Drug market?
What factors are driving Valsartan Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Valsartan Drug market opportunities vary by end market size?
How does Valsartan Drug break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Valsartan Drug Industry Forecast? looks at past sales and reviews total world Valsartan Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Valsartan Drug sales for 2025 through 2031. With Valsartan Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Valsartan Drug industry.
This Insight Report provides a comprehensive analysis of the global Valsartan Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Valsartan Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Valsartan Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Valsartan Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Valsartan Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Valsartan Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 40 mg Tablets
- 80 mg Tablets
- 160 mg Tablets
- 320 mg Tablets
- Hypertension
- Heart Failure
- Heart Attack
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Sun Pharmaceutical
- Teva
- Mylan
- Alembic Pharmaceuticals
- Lupin
- Aurobindo Pharma
- Macleods Pharmaceuticals
- HETERO
- Torrent Pharmaceuticals
- Huaren Pharmaceutical
- Jubilant Pharma
- Amneal Pharmaceuticals
- Zhejiang Huahai Pharmaceutical
- Square Pharmaceuticals
- Unichem Laboratories
What is the 10-year outlook for the global Valsartan Drug market?
What factors are driving Valsartan Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Valsartan Drug market opportunities vary by end market size?
How does Valsartan Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Valsartan Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Valsartan Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Valsartan Drug by Country/Region, 2020, 2024 & 2031
2.2 Valsartan Drug Segment by Type
2.2.1 40 mg Tablets
2.2.2 80 mg Tablets
2.2.3 160 mg Tablets
2.2.4 320 mg Tablets
2.3 Valsartan Drug Sales by Type
2.3.1 Global Valsartan Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Valsartan Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Valsartan Drug Sale Price by Type (2020-2025)
2.4 Valsartan Drug Segment by Application
2.4.1 Hypertension
2.4.2 Heart Failure
2.4.3 Heart Attack
2.5 Valsartan Drug Sales by Application
2.5.1 Global Valsartan Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Valsartan Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Valsartan Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Valsartan Drug Breakdown Data by Company
3.1.1 Global Valsartan Drug Annual Sales by Company (2020-2025)
3.1.2 Global Valsartan Drug Sales Market Share by Company (2020-2025)
3.2 Global Valsartan Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Valsartan Drug Revenue by Company (2020-2025)
3.2.2 Global Valsartan Drug Revenue Market Share by Company (2020-2025)
3.3 Global Valsartan Drug Sale Price by Company
3.4 Key Manufacturers Valsartan Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Valsartan Drug Product Location Distribution
3.4.2 Players Valsartan Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VALSARTAN DRUG BY GEOGRAPHIC REGION
4.1 World Historic Valsartan Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Valsartan Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Valsartan Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Valsartan Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Valsartan Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Valsartan Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Valsartan Drug Sales Growth
4.4 APAC Valsartan Drug Sales Growth
4.5 Europe Valsartan Drug Sales Growth
4.6 Middle East & Africa Valsartan Drug Sales Growth
5 AMERICAS
5.1 Americas Valsartan Drug Sales by Country
5.1.1 Americas Valsartan Drug Sales by Country (2020-2025)
5.1.2 Americas Valsartan Drug Revenue by Country (2020-2025)
5.2 Americas Valsartan Drug Sales by Type (2020-2025)
5.3 Americas Valsartan Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Valsartan Drug Sales by Region
6.1.1 APAC Valsartan Drug Sales by Region (2020-2025)
6.1.2 APAC Valsartan Drug Revenue by Region (2020-2025)
6.2 APAC Valsartan Drug Sales by Type (2020-2025)
6.3 APAC Valsartan Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Valsartan Drug by Country
7.1.1 Europe Valsartan Drug Sales by Country (2020-2025)
7.1.2 Europe Valsartan Drug Revenue by Country (2020-2025)
7.2 Europe Valsartan Drug Sales by Type (2020-2025)
7.3 Europe Valsartan Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Valsartan Drug by Country
8.1.1 Middle East & Africa Valsartan Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Valsartan Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Valsartan Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Valsartan Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Valsartan Drug
10.3 Manufacturing Process Analysis of Valsartan Drug
10.4 Industry Chain Structure of Valsartan Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Valsartan Drug Distributors
11.3 Valsartan Drug Customer
12 WORLD FORECAST REVIEW FOR VALSARTAN DRUG BY GEOGRAPHIC REGION
12.1 Global Valsartan Drug Market Size Forecast by Region
12.1.1 Global Valsartan Drug Forecast by Region (2026-2031)
12.1.2 Global Valsartan Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Valsartan Drug Forecast by Type (2026-2031)
12.7 Global Valsartan Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Valsartan Drug Product Portfolios and Specifications
13.1.3 Novartis Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sun Pharmaceutical
13.2.1 Sun Pharmaceutical Company Information
13.2.2 Sun Pharmaceutical Valsartan Drug Product Portfolios and Specifications
13.2.3 Sun Pharmaceutical Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sun Pharmaceutical Main Business Overview
13.2.5 Sun Pharmaceutical Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Valsartan Drug Product Portfolios and Specifications
13.3.3 Teva Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Valsartan Drug Product Portfolios and Specifications
13.4.3 Mylan Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Alembic Pharmaceuticals
13.5.1 Alembic Pharmaceuticals Company Information
13.5.2 Alembic Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
13.5.3 Alembic Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Alembic Pharmaceuticals Main Business Overview
13.5.5 Alembic Pharmaceuticals Latest Developments
13.6 Lupin
13.6.1 Lupin Company Information
13.6.2 Lupin Valsartan Drug Product Portfolios and Specifications
13.6.3 Lupin Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Lupin Main Business Overview
13.6.5 Lupin Latest Developments
13.7 Aurobindo Pharma
13.7.1 Aurobindo Pharma Company Information
13.7.2 Aurobindo Pharma Valsartan Drug Product Portfolios and Specifications
13.7.3 Aurobindo Pharma Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Aurobindo Pharma Main Business Overview
13.7.5 Aurobindo Pharma Latest Developments
13.8 Macleods Pharmaceuticals
13.8.1 Macleods Pharmaceuticals Company Information
13.8.2 Macleods Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
13.8.3 Macleods Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Macleods Pharmaceuticals Main Business Overview
13.8.5 Macleods Pharmaceuticals Latest Developments
13.9 HETERO
13.9.1 HETERO Company Information
13.9.2 HETERO Valsartan Drug Product Portfolios and Specifications
13.9.3 HETERO Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 HETERO Main Business Overview
13.9.5 HETERO Latest Developments
13.10 Torrent Pharmaceuticals
13.10.1 Torrent Pharmaceuticals Company Information
13.10.2 Torrent Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
13.10.3 Torrent Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Torrent Pharmaceuticals Main Business Overview
13.10.5 Torrent Pharmaceuticals Latest Developments
13.11 Huaren Pharmaceutical
13.11.1 Huaren Pharmaceutical Company Information
13.11.2 Huaren Pharmaceutical Valsartan Drug Product Portfolios and Specifications
13.11.3 Huaren Pharmaceutical Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Huaren Pharmaceutical Main Business Overview
13.11.5 Huaren Pharmaceutical Latest Developments
13.12 Jubilant Pharma
13.12.1 Jubilant Pharma Company Information
13.12.2 Jubilant Pharma Valsartan Drug Product Portfolios and Specifications
13.12.3 Jubilant Pharma Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Jubilant Pharma Main Business Overview
13.12.5 Jubilant Pharma Latest Developments
13.13 Amneal Pharmaceuticals
13.13.1 Amneal Pharmaceuticals Company Information
13.13.2 Amneal Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
13.13.3 Amneal Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Amneal Pharmaceuticals Main Business Overview
13.13.5 Amneal Pharmaceuticals Latest Developments
13.14 Zhejiang Huahai Pharmaceutical
13.14.1 Zhejiang Huahai Pharmaceutical Company Information
13.14.2 Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolios and Specifications
13.14.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.14.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.15 Square Pharmaceuticals
13.15.1 Square Pharmaceuticals Company Information
13.15.2 Square Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
13.15.3 Square Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Square Pharmaceuticals Main Business Overview
13.15.5 Square Pharmaceuticals Latest Developments
13.16 Unichem Laboratories
13.16.1 Unichem Laboratories Company Information
13.16.2 Unichem Laboratories Valsartan Drug Product Portfolios and Specifications
13.16.3 Unichem Laboratories Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Unichem Laboratories Main Business Overview
13.16.5 Unichem Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Valsartan Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Valsartan Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Valsartan Drug by Country/Region, 2020, 2024 & 2031
2.2 Valsartan Drug Segment by Type
2.2.1 40 mg Tablets
2.2.2 80 mg Tablets
2.2.3 160 mg Tablets
2.2.4 320 mg Tablets
2.3 Valsartan Drug Sales by Type
2.3.1 Global Valsartan Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Valsartan Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Valsartan Drug Sale Price by Type (2020-2025)
2.4 Valsartan Drug Segment by Application
2.4.1 Hypertension
2.4.2 Heart Failure
2.4.3 Heart Attack
2.5 Valsartan Drug Sales by Application
2.5.1 Global Valsartan Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Valsartan Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Valsartan Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Valsartan Drug Breakdown Data by Company
3.1.1 Global Valsartan Drug Annual Sales by Company (2020-2025)
3.1.2 Global Valsartan Drug Sales Market Share by Company (2020-2025)
3.2 Global Valsartan Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Valsartan Drug Revenue by Company (2020-2025)
3.2.2 Global Valsartan Drug Revenue Market Share by Company (2020-2025)
3.3 Global Valsartan Drug Sale Price by Company
3.4 Key Manufacturers Valsartan Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Valsartan Drug Product Location Distribution
3.4.2 Players Valsartan Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VALSARTAN DRUG BY GEOGRAPHIC REGION
4.1 World Historic Valsartan Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Valsartan Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Valsartan Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Valsartan Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Valsartan Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Valsartan Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Valsartan Drug Sales Growth
4.4 APAC Valsartan Drug Sales Growth
4.5 Europe Valsartan Drug Sales Growth
4.6 Middle East & Africa Valsartan Drug Sales Growth
5 AMERICAS
5.1 Americas Valsartan Drug Sales by Country
5.1.1 Americas Valsartan Drug Sales by Country (2020-2025)
5.1.2 Americas Valsartan Drug Revenue by Country (2020-2025)
5.2 Americas Valsartan Drug Sales by Type (2020-2025)
5.3 Americas Valsartan Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Valsartan Drug Sales by Region
6.1.1 APAC Valsartan Drug Sales by Region (2020-2025)
6.1.2 APAC Valsartan Drug Revenue by Region (2020-2025)
6.2 APAC Valsartan Drug Sales by Type (2020-2025)
6.3 APAC Valsartan Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Valsartan Drug by Country
7.1.1 Europe Valsartan Drug Sales by Country (2020-2025)
7.1.2 Europe Valsartan Drug Revenue by Country (2020-2025)
7.2 Europe Valsartan Drug Sales by Type (2020-2025)
7.3 Europe Valsartan Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Valsartan Drug by Country
8.1.1 Middle East & Africa Valsartan Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Valsartan Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Valsartan Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Valsartan Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Valsartan Drug
10.3 Manufacturing Process Analysis of Valsartan Drug
10.4 Industry Chain Structure of Valsartan Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Valsartan Drug Distributors
11.3 Valsartan Drug Customer
12 WORLD FORECAST REVIEW FOR VALSARTAN DRUG BY GEOGRAPHIC REGION
12.1 Global Valsartan Drug Market Size Forecast by Region
12.1.1 Global Valsartan Drug Forecast by Region (2026-2031)
12.1.2 Global Valsartan Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Valsartan Drug Forecast by Type (2026-2031)
12.7 Global Valsartan Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Valsartan Drug Product Portfolios and Specifications
13.1.3 Novartis Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sun Pharmaceutical
13.2.1 Sun Pharmaceutical Company Information
13.2.2 Sun Pharmaceutical Valsartan Drug Product Portfolios and Specifications
13.2.3 Sun Pharmaceutical Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sun Pharmaceutical Main Business Overview
13.2.5 Sun Pharmaceutical Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Valsartan Drug Product Portfolios and Specifications
13.3.3 Teva Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Valsartan Drug Product Portfolios and Specifications
13.4.3 Mylan Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Alembic Pharmaceuticals
13.5.1 Alembic Pharmaceuticals Company Information
13.5.2 Alembic Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
13.5.3 Alembic Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Alembic Pharmaceuticals Main Business Overview
13.5.5 Alembic Pharmaceuticals Latest Developments
13.6 Lupin
13.6.1 Lupin Company Information
13.6.2 Lupin Valsartan Drug Product Portfolios and Specifications
13.6.3 Lupin Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Lupin Main Business Overview
13.6.5 Lupin Latest Developments
13.7 Aurobindo Pharma
13.7.1 Aurobindo Pharma Company Information
13.7.2 Aurobindo Pharma Valsartan Drug Product Portfolios and Specifications
13.7.3 Aurobindo Pharma Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Aurobindo Pharma Main Business Overview
13.7.5 Aurobindo Pharma Latest Developments
13.8 Macleods Pharmaceuticals
13.8.1 Macleods Pharmaceuticals Company Information
13.8.2 Macleods Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
13.8.3 Macleods Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Macleods Pharmaceuticals Main Business Overview
13.8.5 Macleods Pharmaceuticals Latest Developments
13.9 HETERO
13.9.1 HETERO Company Information
13.9.2 HETERO Valsartan Drug Product Portfolios and Specifications
13.9.3 HETERO Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 HETERO Main Business Overview
13.9.5 HETERO Latest Developments
13.10 Torrent Pharmaceuticals
13.10.1 Torrent Pharmaceuticals Company Information
13.10.2 Torrent Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
13.10.3 Torrent Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Torrent Pharmaceuticals Main Business Overview
13.10.5 Torrent Pharmaceuticals Latest Developments
13.11 Huaren Pharmaceutical
13.11.1 Huaren Pharmaceutical Company Information
13.11.2 Huaren Pharmaceutical Valsartan Drug Product Portfolios and Specifications
13.11.3 Huaren Pharmaceutical Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Huaren Pharmaceutical Main Business Overview
13.11.5 Huaren Pharmaceutical Latest Developments
13.12 Jubilant Pharma
13.12.1 Jubilant Pharma Company Information
13.12.2 Jubilant Pharma Valsartan Drug Product Portfolios and Specifications
13.12.3 Jubilant Pharma Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Jubilant Pharma Main Business Overview
13.12.5 Jubilant Pharma Latest Developments
13.13 Amneal Pharmaceuticals
13.13.1 Amneal Pharmaceuticals Company Information
13.13.2 Amneal Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
13.13.3 Amneal Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Amneal Pharmaceuticals Main Business Overview
13.13.5 Amneal Pharmaceuticals Latest Developments
13.14 Zhejiang Huahai Pharmaceutical
13.14.1 Zhejiang Huahai Pharmaceutical Company Information
13.14.2 Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolios and Specifications
13.14.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.14.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.15 Square Pharmaceuticals
13.15.1 Square Pharmaceuticals Company Information
13.15.2 Square Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
13.15.3 Square Pharmaceuticals Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Square Pharmaceuticals Main Business Overview
13.15.5 Square Pharmaceuticals Latest Developments
13.16 Unichem Laboratories
13.16.1 Unichem Laboratories Company Information
13.16.2 Unichem Laboratories Valsartan Drug Product Portfolios and Specifications
13.16.3 Unichem Laboratories Valsartan Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Unichem Laboratories Main Business Overview
13.16.5 Unichem Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Valsartan Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Valsartan Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 40 mgTablets
Table 4. Major Players of 80 mgTablets
Table 5. Major Players of 160 mgTablets
Table 6. Major Players of 320 mgTablets
Table 7. Global Valsartan Drug Sales by Type (2020-2025) & (K Units)
Table 8. Global Valsartan Drug Sales Market Share by Type (2020-2025)
Table 9. Global Valsartan Drug Revenue by Type (2020-2025) & ($ million)
Table 10. Global Valsartan Drug Revenue Market Share by Type (2020-2025)
Table 11. Global Valsartan Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Valsartan Drug Sale by Application (2020-2025) & (K Units)
Table 13. Global Valsartan Drug Sale Market Share by Application (2020-2025)
Table 14. Global Valsartan Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Valsartan Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Valsartan Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Valsartan Drug Sales by Company (2020-2025) & (K Units)
Table 18. Global Valsartan Drug Sales Market Share by Company (2020-2025)
Table 19. Global Valsartan Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Valsartan Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Valsartan Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Valsartan Drug Producing Area Distribution and Sales Area
Table 23. Players Valsartan Drug Products Offered
Table 24. Valsartan Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Valsartan Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Valsartan Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Valsartan Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Valsartan Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Valsartan Drug Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Valsartan Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Valsartan Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Valsartan Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Valsartan Drug Sales by Country (2020-2025) & (K Units)
Table 36. Americas Valsartan Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Valsartan Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Valsartan Drug Sales by Type (2020-2025) & (K Units)
Table 39. Americas Valsartan Drug Sales by Application (2020-2025) & (K Units)
Table 40. APAC Valsartan Drug Sales by Region (2020-2025) & (K Units)
Table 41. APAC Valsartan Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Valsartan Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Valsartan Drug Sales by Type (2020-2025) & (K Units)
Table 44. APAC Valsartan Drug Sales by Application (2020-2025) & (K Units)
Table 45. Europe Valsartan Drug Sales by Country (2020-2025) & (K Units)
Table 46. Europe Valsartan Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Valsartan Drug Sales by Type (2020-2025) & (K Units)
Table 48. Europe Valsartan Drug Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Valsartan Drug Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Valsartan Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Valsartan Drug Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Valsartan Drug Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Valsartan Drug
Table 54. Key Market Challenges & Risks of Valsartan Drug
Table 55. Key Industry Trends of Valsartan Drug
Table 56. Valsartan Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Valsartan Drug Distributors List
Table 59. Valsartan Drug Customer List
Table 60. Global Valsartan Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Valsartan Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Valsartan Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Valsartan Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Valsartan Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Valsartan Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Valsartan Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Valsartan Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Valsartan Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Valsartan Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Valsartan Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Valsartan Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Valsartan Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Valsartan Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Novartis Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 75. Novartis Valsartan Drug Product Portfolios and Specifications
Table 76. Novartis Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Novartis Main Business
Table 78. Novartis Latest Developments
Table 79. Sun Pharmaceutical Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Sun Pharmaceutical Valsartan Drug Product Portfolios and Specifications
Table 81. Sun Pharmaceutical Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Sun Pharmaceutical Main Business
Table 83. Sun Pharmaceutical Latest Developments
Table 84. Teva Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Teva Valsartan Drug Product Portfolios and Specifications
Table 86. Teva Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Teva Main Business
Table 88. Teva Latest Developments
Table 89. Mylan Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Mylan Valsartan Drug Product Portfolios and Specifications
Table 91. Mylan Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Mylan Main Business
Table 93. Mylan Latest Developments
Table 94. Alembic Pharmaceuticals Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Alembic Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
Table 96. Alembic Pharmaceuticals Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Alembic Pharmaceuticals Main Business
Table 98. Alembic Pharmaceuticals Latest Developments
Table 99. Lupin Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Lupin Valsartan Drug Product Portfolios and Specifications
Table 101. Lupin Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Lupin Main Business
Table 103. Lupin Latest Developments
Table 104. Aurobindo Pharma Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Aurobindo Pharma Valsartan Drug Product Portfolios and Specifications
Table 106. Aurobindo Pharma Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Aurobindo Pharma Main Business
Table 108. Aurobindo Pharma Latest Developments
Table 109. Macleods Pharmaceuticals Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Macleods Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
Table 111. Macleods Pharmaceuticals Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Macleods Pharmaceuticals Main Business
Table 113. Macleods Pharmaceuticals Latest Developments
Table 114. HETERO Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. HETERO Valsartan Drug Product Portfolios and Specifications
Table 116. HETERO Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. HETERO Main Business
Table 118. HETERO Latest Developments
Table 119. Torrent Pharmaceuticals Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Torrent Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
Table 121. Torrent Pharmaceuticals Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Torrent Pharmaceuticals Main Business
Table 123. Torrent Pharmaceuticals Latest Developments
Table 124. Huaren Pharmaceutical Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Huaren Pharmaceutical Valsartan Drug Product Portfolios and Specifications
Table 126. Huaren Pharmaceutical Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Huaren Pharmaceutical Main Business
Table 128. Huaren Pharmaceutical Latest Developments
Table 129. Jubilant Pharma Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Jubilant Pharma Valsartan Drug Product Portfolios and Specifications
Table 131. Jubilant Pharma Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Jubilant Pharma Main Business
Table 133. Jubilant Pharma Latest Developments
Table 134. Amneal Pharmaceuticals Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 135. Amneal Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
Table 136. Amneal Pharmaceuticals Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Amneal Pharmaceuticals Main Business
Table 138. Amneal Pharmaceuticals Latest Developments
Table 139. Zhejiang Huahai Pharmaceutical Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 140. Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolios and Specifications
Table 141. Zhejiang Huahai Pharmaceutical Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Zhejiang Huahai Pharmaceutical Main Business
Table 143. Zhejiang Huahai Pharmaceutical Latest Developments
Table 144. Square Pharmaceuticals Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 145. Square Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
Table 146. Square Pharmaceuticals Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Square Pharmaceuticals Main Business
Table 148. Square Pharmaceuticals Latest Developments
Table 149. Unichem Laboratories Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 150. Unichem Laboratories Valsartan Drug Product Portfolios and Specifications
Table 151. Unichem Laboratories Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Unichem Laboratories Main Business
Table 153. Unichem Laboratories Latest Developments
Table 1. Valsartan Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Valsartan Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 40 mgTablets
Table 4. Major Players of 80 mgTablets
Table 5. Major Players of 160 mgTablets
Table 6. Major Players of 320 mgTablets
Table 7. Global Valsartan Drug Sales by Type (2020-2025) & (K Units)
Table 8. Global Valsartan Drug Sales Market Share by Type (2020-2025)
Table 9. Global Valsartan Drug Revenue by Type (2020-2025) & ($ million)
Table 10. Global Valsartan Drug Revenue Market Share by Type (2020-2025)
Table 11. Global Valsartan Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Valsartan Drug Sale by Application (2020-2025) & (K Units)
Table 13. Global Valsartan Drug Sale Market Share by Application (2020-2025)
Table 14. Global Valsartan Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Valsartan Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Valsartan Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Valsartan Drug Sales by Company (2020-2025) & (K Units)
Table 18. Global Valsartan Drug Sales Market Share by Company (2020-2025)
Table 19. Global Valsartan Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Valsartan Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Valsartan Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Valsartan Drug Producing Area Distribution and Sales Area
Table 23. Players Valsartan Drug Products Offered
Table 24. Valsartan Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Valsartan Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Valsartan Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Valsartan Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Valsartan Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Valsartan Drug Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Valsartan Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Valsartan Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Valsartan Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Valsartan Drug Sales by Country (2020-2025) & (K Units)
Table 36. Americas Valsartan Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Valsartan Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Valsartan Drug Sales by Type (2020-2025) & (K Units)
Table 39. Americas Valsartan Drug Sales by Application (2020-2025) & (K Units)
Table 40. APAC Valsartan Drug Sales by Region (2020-2025) & (K Units)
Table 41. APAC Valsartan Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Valsartan Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Valsartan Drug Sales by Type (2020-2025) & (K Units)
Table 44. APAC Valsartan Drug Sales by Application (2020-2025) & (K Units)
Table 45. Europe Valsartan Drug Sales by Country (2020-2025) & (K Units)
Table 46. Europe Valsartan Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Valsartan Drug Sales by Type (2020-2025) & (K Units)
Table 48. Europe Valsartan Drug Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Valsartan Drug Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Valsartan Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Valsartan Drug Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Valsartan Drug Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Valsartan Drug
Table 54. Key Market Challenges & Risks of Valsartan Drug
Table 55. Key Industry Trends of Valsartan Drug
Table 56. Valsartan Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Valsartan Drug Distributors List
Table 59. Valsartan Drug Customer List
Table 60. Global Valsartan Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Valsartan Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Valsartan Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Valsartan Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Valsartan Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Valsartan Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Valsartan Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Valsartan Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Valsartan Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Valsartan Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Valsartan Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Valsartan Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Valsartan Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Valsartan Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Novartis Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 75. Novartis Valsartan Drug Product Portfolios and Specifications
Table 76. Novartis Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Novartis Main Business
Table 78. Novartis Latest Developments
Table 79. Sun Pharmaceutical Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Sun Pharmaceutical Valsartan Drug Product Portfolios and Specifications
Table 81. Sun Pharmaceutical Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Sun Pharmaceutical Main Business
Table 83. Sun Pharmaceutical Latest Developments
Table 84. Teva Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Teva Valsartan Drug Product Portfolios and Specifications
Table 86. Teva Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Teva Main Business
Table 88. Teva Latest Developments
Table 89. Mylan Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Mylan Valsartan Drug Product Portfolios and Specifications
Table 91. Mylan Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Mylan Main Business
Table 93. Mylan Latest Developments
Table 94. Alembic Pharmaceuticals Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Alembic Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
Table 96. Alembic Pharmaceuticals Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Alembic Pharmaceuticals Main Business
Table 98. Alembic Pharmaceuticals Latest Developments
Table 99. Lupin Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Lupin Valsartan Drug Product Portfolios and Specifications
Table 101. Lupin Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Lupin Main Business
Table 103. Lupin Latest Developments
Table 104. Aurobindo Pharma Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Aurobindo Pharma Valsartan Drug Product Portfolios and Specifications
Table 106. Aurobindo Pharma Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Aurobindo Pharma Main Business
Table 108. Aurobindo Pharma Latest Developments
Table 109. Macleods Pharmaceuticals Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Macleods Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
Table 111. Macleods Pharmaceuticals Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Macleods Pharmaceuticals Main Business
Table 113. Macleods Pharmaceuticals Latest Developments
Table 114. HETERO Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. HETERO Valsartan Drug Product Portfolios and Specifications
Table 116. HETERO Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. HETERO Main Business
Table 118. HETERO Latest Developments
Table 119. Torrent Pharmaceuticals Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Torrent Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
Table 121. Torrent Pharmaceuticals Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Torrent Pharmaceuticals Main Business
Table 123. Torrent Pharmaceuticals Latest Developments
Table 124. Huaren Pharmaceutical Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Huaren Pharmaceutical Valsartan Drug Product Portfolios and Specifications
Table 126. Huaren Pharmaceutical Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Huaren Pharmaceutical Main Business
Table 128. Huaren Pharmaceutical Latest Developments
Table 129. Jubilant Pharma Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Jubilant Pharma Valsartan Drug Product Portfolios and Specifications
Table 131. Jubilant Pharma Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Jubilant Pharma Main Business
Table 133. Jubilant Pharma Latest Developments
Table 134. Amneal Pharmaceuticals Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 135. Amneal Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
Table 136. Amneal Pharmaceuticals Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Amneal Pharmaceuticals Main Business
Table 138. Amneal Pharmaceuticals Latest Developments
Table 139. Zhejiang Huahai Pharmaceutical Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 140. Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolios and Specifications
Table 141. Zhejiang Huahai Pharmaceutical Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Zhejiang Huahai Pharmaceutical Main Business
Table 143. Zhejiang Huahai Pharmaceutical Latest Developments
Table 144. Square Pharmaceuticals Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 145. Square Pharmaceuticals Valsartan Drug Product Portfolios and Specifications
Table 146. Square Pharmaceuticals Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Square Pharmaceuticals Main Business
Table 148. Square Pharmaceuticals Latest Developments
Table 149. Unichem Laboratories Basic Information, Valsartan Drug Manufacturing Base, Sales Area and Its Competitors
Table 150. Unichem Laboratories Valsartan Drug Product Portfolios and Specifications
Table 151. Unichem Laboratories Valsartan Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Unichem Laboratories Main Business
Table 153. Unichem Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Picture of Valsartan Drug
Figure 2. Valsartan Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Valsartan Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Valsartan Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Valsartan Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Valsartan Drug Sales Market Share by Country/Region (2024)
Figure 10. Valsartan Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 40 mgTablets
Figure 12. Product Picture of 80 mgTablets
Figure 13. Product Picture of 160 mgTablets
Figure 14. Product Picture of 320 mgTablets
Figure 15. Global Valsartan Drug Sales Market Share by Type in 2025
Figure 16. Global Valsartan Drug Revenue Market Share by Type (2020-2025)
Figure 17. Valsartan Drug Consumed in Hypertension
Figure 18. Global Valsartan Drug Market: Hypertension (2020-2025) & (K Units)
Figure 19. Valsartan Drug Consumed in Heart Failure
Figure 20. Global Valsartan Drug Market: Heart Failure (2020-2025) & (K Units)
Figure 21. Valsartan Drug Consumed in Heart Attack
Figure 22. Global Valsartan Drug Market: Heart Attack (2020-2025) & (K Units)
Figure 23. Global Valsartan Drug Sale Market Share by Application (2024)
Figure 24. Global Valsartan Drug Revenue Market Share by Application in 2025
Figure 25. Valsartan Drug Sales by Company in 2025 (K Units)
Figure 26. Global Valsartan Drug Sales Market Share by Company in 2025
Figure 27. Valsartan Drug Revenue by Company in 2025 ($ millions)
Figure 28. Global Valsartan Drug Revenue Market Share by Company in 2025
Figure 29. Global Valsartan Drug Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Valsartan Drug Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Valsartan Drug Sales 2020-2025 (K Units)
Figure 32. Americas Valsartan Drug Revenue 2020-2025 ($ millions)
Figure 33. APAC Valsartan Drug Sales 2020-2025 (K Units)
Figure 34. APAC Valsartan Drug Revenue 2020-2025 ($ millions)
Figure 35. Europe Valsartan Drug Sales 2020-2025 (K Units)
Figure 36. Europe Valsartan Drug Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Valsartan Drug Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Valsartan Drug Revenue 2020-2025 ($ millions)
Figure 39. Americas Valsartan Drug Sales Market Share by Country in 2025
Figure 40. Americas Valsartan Drug Revenue Market Share by Country (2020-2025)
Figure 41. Americas Valsartan Drug Sales Market Share by Type (2020-2025)
Figure 42. Americas Valsartan Drug Sales Market Share by Application (2020-2025)
Figure 43. United States Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Valsartan Drug Sales Market Share by Region in 2025
Figure 48. APAC Valsartan Drug Revenue Market Share by Region (2020-2025)
Figure 49. APAC Valsartan Drug Sales Market Share by Type (2020-2025)
Figure 50. APAC Valsartan Drug Sales Market Share by Application (2020-2025)
Figure 51. China Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. India Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Valsartan Drug Sales Market Share by Country in 2025
Figure 59. Europe Valsartan Drug Revenue Market Share by Country (2020-2025)
Figure 60. Europe Valsartan Drug Sales Market Share by Type (2020-2025)
Figure 61. Europe Valsartan Drug Sales Market Share by Application (2020-2025)
Figure 62. Germany Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. France Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Valsartan Drug Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Valsartan Drug Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Valsartan Drug Sales Market Share by Application (2020-2025)
Figure 70. Egypt Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Valsartan Drug in 2025
Figure 76. Manufacturing Process Analysis of Valsartan Drug
Figure 77. Industry Chain Structure of Valsartan Drug
Figure 78. Channels of Distribution
Figure 79. Global Valsartan Drug Sales Market Forecast by Region (2026-2031)
Figure 80. Global Valsartan Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Valsartan Drug Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Valsartan Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Valsartan Drug Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Valsartan Drug Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Valsartan Drug
Figure 2. Valsartan Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Valsartan Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Valsartan Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Valsartan Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Valsartan Drug Sales Market Share by Country/Region (2024)
Figure 10. Valsartan Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 40 mgTablets
Figure 12. Product Picture of 80 mgTablets
Figure 13. Product Picture of 160 mgTablets
Figure 14. Product Picture of 320 mgTablets
Figure 15. Global Valsartan Drug Sales Market Share by Type in 2025
Figure 16. Global Valsartan Drug Revenue Market Share by Type (2020-2025)
Figure 17. Valsartan Drug Consumed in Hypertension
Figure 18. Global Valsartan Drug Market: Hypertension (2020-2025) & (K Units)
Figure 19. Valsartan Drug Consumed in Heart Failure
Figure 20. Global Valsartan Drug Market: Heart Failure (2020-2025) & (K Units)
Figure 21. Valsartan Drug Consumed in Heart Attack
Figure 22. Global Valsartan Drug Market: Heart Attack (2020-2025) & (K Units)
Figure 23. Global Valsartan Drug Sale Market Share by Application (2024)
Figure 24. Global Valsartan Drug Revenue Market Share by Application in 2025
Figure 25. Valsartan Drug Sales by Company in 2025 (K Units)
Figure 26. Global Valsartan Drug Sales Market Share by Company in 2025
Figure 27. Valsartan Drug Revenue by Company in 2025 ($ millions)
Figure 28. Global Valsartan Drug Revenue Market Share by Company in 2025
Figure 29. Global Valsartan Drug Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Valsartan Drug Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Valsartan Drug Sales 2020-2025 (K Units)
Figure 32. Americas Valsartan Drug Revenue 2020-2025 ($ millions)
Figure 33. APAC Valsartan Drug Sales 2020-2025 (K Units)
Figure 34. APAC Valsartan Drug Revenue 2020-2025 ($ millions)
Figure 35. Europe Valsartan Drug Sales 2020-2025 (K Units)
Figure 36. Europe Valsartan Drug Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Valsartan Drug Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Valsartan Drug Revenue 2020-2025 ($ millions)
Figure 39. Americas Valsartan Drug Sales Market Share by Country in 2025
Figure 40. Americas Valsartan Drug Revenue Market Share by Country (2020-2025)
Figure 41. Americas Valsartan Drug Sales Market Share by Type (2020-2025)
Figure 42. Americas Valsartan Drug Sales Market Share by Application (2020-2025)
Figure 43. United States Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Valsartan Drug Sales Market Share by Region in 2025
Figure 48. APAC Valsartan Drug Revenue Market Share by Region (2020-2025)
Figure 49. APAC Valsartan Drug Sales Market Share by Type (2020-2025)
Figure 50. APAC Valsartan Drug Sales Market Share by Application (2020-2025)
Figure 51. China Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. India Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Valsartan Drug Sales Market Share by Country in 2025
Figure 59. Europe Valsartan Drug Revenue Market Share by Country (2020-2025)
Figure 60. Europe Valsartan Drug Sales Market Share by Type (2020-2025)
Figure 61. Europe Valsartan Drug Sales Market Share by Application (2020-2025)
Figure 62. Germany Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. France Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Valsartan Drug Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Valsartan Drug Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Valsartan Drug Sales Market Share by Application (2020-2025)
Figure 70. Egypt Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Valsartan Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Valsartan Drug in 2025
Figure 76. Manufacturing Process Analysis of Valsartan Drug
Figure 77. Industry Chain Structure of Valsartan Drug
Figure 78. Channels of Distribution
Figure 79. Global Valsartan Drug Sales Market Forecast by Region (2026-2031)
Figure 80. Global Valsartan Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Valsartan Drug Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Valsartan Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Valsartan Drug Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Valsartan Drug Revenue Market Share Forecast by Application (2026-2031)
More Publications
Investigation Report on China Valsartan Market, 2009-2018
US$ 1,800.00
February 2014
40 pages
